Open-label Study of Bevacizumab Maintenance Therapy (AVASTIN) With or Without Pemetrexed After First-line Chemotherapy With Bevacizumab-cisplatin-pemetrexed in Patients With Advanced, Metastatic or Recurrent Non-squamous Non-small Cell Lung Cancer (NSCLC).
Phase of Trial: Phase III
Latest Information Update: 24 Feb 2016
At a glance
- Drugs Bevacizumab (Primary) ; Cisplatin; Pemetrexed
- Indications Non-small cell lung cancer
- Focus Registrational; Therapeutic Use
- Acronyms AVAPERL; AVAPERL-1
- Sponsors Roche
- 30 Jan 2014 Last checked against German Clinical Trials Register, DRKS00003765.
- 08 Jul 2013 Results published in the Journal of Clinical Oncology.
- 04 Jun 2013 Updated overall survival analysis presented at the 49th Annual Meeting of the American Society of Clinical Oncology.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History